IRAP

Interleukin-1 Receptor Antagonist Protein (IRAP)

Interleukin-1 Receptor Antagonist Protein Procession System, blocks the excessive production of synovial fluid in joints affected by osteoarthritis. This fluid carries a protein called interleukin-1, which plays an important role in inflammation and accelerates the deterioration of tissue.

The treatment works by taking a sample of blood from the injured horse and incubating it for 24 hours in a syringe filled with beads coated with substances that encourage healing, such as growth factors and anti-inflammatory aids.

The sample is then “spun” to separate these beneficial substances from red blood cells. The beneficial fluid is then injected into the injured joint three to five times, encouraging healing. The treatment also drastically reduces the animal’s susceptibility to infection and immune reactions because the fluid is a derivative of its own blood.